Correlation Between Salesforce and Allarity Therapeutics
Can any of the company-specific risk be diversified away by investing in both Salesforce and Allarity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Allarity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Allarity Therapeutics, you can compare the effects of market volatilities on Salesforce and Allarity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Allarity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Allarity Therapeutics.
Diversification Opportunities for Salesforce and Allarity Therapeutics
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salesforce and Allarity is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Allarity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allarity Therapeutics and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Allarity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allarity Therapeutics has no effect on the direction of Salesforce i.e., Salesforce and Allarity Therapeutics go up and down completely randomly.
Pair Corralation between Salesforce and Allarity Therapeutics
Considering the 90-day investment horizon Salesforce is expected to generate 0.55 times more return on investment than Allarity Therapeutics. However, Salesforce is 1.83 times less risky than Allarity Therapeutics. It trades about 0.34 of its potential returns per unit of risk. Allarity Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 29,377 in Salesforce on August 27, 2024 and sell it today you would earn a total of 4,534 from holding Salesforce or generate 15.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Allarity Therapeutics
Performance |
| Timeline |
| Salesforce |
| Allarity Therapeutics |
Salesforce and Allarity Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Allarity Therapeutics
The main advantage of trading using opposite Salesforce and Allarity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Allarity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will offset losses from the drop in Allarity Therapeutics' long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |